Themístocles Mesquitas Teles de Carvalho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Themístocles Mesquitas Teles de Carvalho has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Camila Monteiro Veras
Hospital Geral de Fortaleza, Brazil
2 shared publications - Camilla Bezerra Bastos Limeira
Hospital Geral de Fortaleza, Brazil
2 shared publications - Ivelise Regina Canito Brasil
Hospital Geral de Fortaleza, Brazil; Universidade Estadual do Ceará, Brazil
2 shared publications - José Hícaro Hellano Gonçalves Lima Paiva
Hospital Geral Dr Cesar Carls
2 shared publications - Marina Seixas Studart e Neves
Center for Interventional Psychiatry, Faillace Department of Psychiatry and Behavioral Sciences at McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054, USA
2 shared publications - Natália Stefani de Assunção Ferreira
Universidade Estadual do Ceará, Brazil
2 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Elsevier in SSRN Electronic Journal
Renoportal Anastomosis for Portal Inflow Reconstruction During Liver Transplantation: A Single-Center Case Series From Northeastern Brazil
BackgroundRenoportal anastomosis may restore physiologic portal inflow in selected liver transplant recipients with Yerdel grade IV portal vein thrombosis and splenorenal shunts. We evaluated direct end-to-end reconstruction without an interposition graft.MethodsThis retrospective case series included adult recipients with planned renoportal reconstruction at a liver transplant center in northeastern Brazil between December 2024 and May 2026. Outcomes were analyzed descriptively, with completed reconstructions comprising the primary cohort.ResultsAmong 71 liver transplants, six recipients were considered for renoportal reconstruction, which was completed in five. Uncontrolled intraoperative bleeding prevented completion in one patient, who died in the immediate postoperative period. Among completed cases, median age was 33 years and MELD-Na was 23. All five had splenorenal shunts and underwent direct anastomosis without interposition grafts. Functional portal inflow was maintained in all, without reconstruction-related vascular intervention. Three patients underwent reoperation, none for renoportal failure. Early allograft dysfunction occurred in three of four evaluable patients. All five developed KDIGO stage 3 acute kidney injury; two required temporary renal replacement therapy. Median follow-up was 179 days (range, 72–537). Four patients remained alive; one died on postoperative day 72 following osmotic demyelination syndrome and infectious complications.ConclusionDirect renoportal anastomosis maintained functional portal inflow in selected recipients with Yerdel grade IV thrombosis and splenorenal shunts. Despite substantial postoperative morbidity, no reconstruction-related vascular intervention was required during follow-up. Larger studies with standardized vascular and renal follow-up are needed to establish durability and comparative outcomes.
- 15 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessRenoportal Anastomosis for Portal Inflow Reconstruction During Liver Transplantation: A Single-Center Case Series From Northeastern Brazil
BackgroundRenoportal anastomosis may restore physiologic portal inflow in selected liver transplant recipients with Yerdel grade IV portal vein thrombosis and splenorenal shunts. We evaluated direct end-to-end reconstruction without an interposition graft.MethodsThis retrospective case series included adult recipients with planned renoportal reconstruction at a liver transplant center in northeastern Brazil between December 2024 and May 2026. Outcomes were analyzed descriptively, with completed reconstructions comprising the primary cohort.ResultsAmong 71 liver transplants, six recipients were considered for renoportal reconstruction, which was completed in five. Uncontrolled intraoperative bleeding prevented completion in one patient, who died in the immediate postoperative period. Among completed cases, median age was 33 years and MELD-Na was 23. All five had splenorenal shunts and underwent direct anastomosis without interposition grafts. Functional portal inflow was maintained in all, without reconstruction-related vascular intervention. Three patients underwent reoperation, none for renoportal failure. Early allograft dysfunction occurred in three of four evaluable patients. All five developed KDIGO stage 3 acute kidney injury; two required temporary renal replacement therapy. Median follow-up was 179 days (range, 72–537). Four patients remained alive; one died on postoperative day 72 following osmotic demyelination syndrome and infectious complications.ConclusionDirect renoportal anastomosis maintained functional portal inflow in selected recipients with Yerdel grade IV thrombosis and splenorenal shunts. Despite substantial postoperative morbidity, no reconstruction-related vascular intervention was required during follow-up. Larger studies with standardized vascular and renal follow-up are needed to establish durability and comparative outcomes.
- Open Access
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 64, e8
Impact of COVID-19 on liver transplant recipients during the first pandemic wave, in a tertiary hospital, in Northeastern Brazil
Worldwide, transplant programs have suffered a setback during the coronavirus disease 2019 (COVID-19) pandemic and most have temporarily suspended their transplant activities. . We identified 36 liver transplant patients who tested positive for COVID-19. The cases were confirmed by the nucleic acid test (RT-PCR). Epidemiological, demographic, clinical, laboratory, management and outcome data were obtained from the patients’ medical records. Fourteen patients (38.9%) required admission to the Intensive Care Unit and/or invasive ventilatory support (severe cases). The mean age of these severe cases was 63.8 years. Regarding the time since the transplant, 71.4% (10/14 patients) had undergone the procedure less than one year before. The immunosuppressive therapy was reduced in patients who required Intensive Care Unit. A total of 12 cases (12/14, 85.7%) required invasive ventilatory support. Eight cases (8/14, 57.1%) required renal replacement therapy. In this group of patients, nine died (64.3 %). In turn, 22 patients had mild to moderate symptoms of COVID-19, not requiring invasive ventilatory support or admission to the Intensive Care Unit. The mean age in these patients was 56.5 years and comorbidities were present in 15 (68.2%) of the cases. In this group, only five patients (5/22, 22.7%) required hospitalization due to complications and there were no deaths This report describes the results of COVID-19 infection in a very specific population, suggesting that liver transplant patients have a significant higher risk of progressing to severeCOVID-19 , with a mortality rate among critically-ill patients above that of the general population.
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 64, e8
Open AccessImpact of COVID-19 on liver transplant recipients during the first pandemic wave, in a tertiary hospital, in Northeastern Brazil
Worldwide, transplant programs have suffered a setback during the coronavirus disease 2019 (COVID-19) pandemic and most have temporarily suspended their transplant activities. . We identified 36 liver transplant patients who tested positive for COVID-19. The cases were confirmed by the nucleic acid test (RT-PCR). Epidemiological, demographic, clinical, laboratory, management and outcome data were obtained from the patients’ medical records. Fourteen patients (38.9%) required admission to the Intensive Care Unit and/or invasive ventilatory support (severe cases). The mean age of these severe cases was 63.8 years. Regarding the time since the transplant, 71.4% (10/14 patients) had undergone the procedure less than one year before. The immunosuppressive therapy was reduced in patients who required Intensive Care Unit. A total of 12 cases (12/14, 85.7%) required invasive ventilatory support. Eight cases (8/14, 57.1%) required renal replacement therapy. In this group of patients, nine died (64.3 %). In turn, 22 patients had mild to moderate symptoms of COVID-19, not requiring invasive ventilatory support or admission to the Intensive Care Unit. The mean age in these patients was 56.5 years and comorbidities were present in 15 (68.2%) of the cases. In this group, only five patients (5/22, 22.7%) required hospitalization due to complications and there were no deaths This report describes the results of COVID-19 infection in a very specific population, suggesting that liver transplant patients have a significant higher risk of progressing to severeCOVID-19 , with a mortality rate among critically-ill patients above that of the general population.
- Open Access
- 14 November 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (15)
Estrongiloidíase disseminada em paciente de transplante renal e pancreático: revisão de literatura baseado em caso clínico
O Strongyloides stercoralis é um helminto com distribuição mundial. As manifestações clínicas da estrongiloidíase disseminada variam amplamente e os pacientes imunocomprometidos apresentam risco de infecção sintomática. Um paciente do sexo masculino de 38 anos foi submetido a transplante duplo de pâncreas-rim em dezembro de 2019 devido a diabetes mellitus tipo 1 e insuficiência renal crônica dialítica. O transplante ocorreu sem maiores intercorrências e o mesmo recebeu alta 10 dias após a realização do procedimento. Sessenta dias após o transplante foi internado na enfermaria de transplante renal apresentando náuseas, vômitos e dores abdominais iniciadas 5 dias antes. Com a possibilidade diagnóstica de gastroenterite infecciosa, foi iniciada antibioticoterapia. O paciente evoluiu com piora ventilatória associada a declínio do sensório, sendo encaminhado para Unidade de Terapia Intensiva, onde foi intubado e colocado em suporte ventilatório. Devido a piora clínica e hemodinâmica, necessitou iniciar de drogas vasoativas e aumentar o espectro da antibioticoterapia. Observou-se lesão serpiginosa púrpura em abdome, surgindo então a possibilidade de estrongiloidíase disseminada, posteriormente confirmada por lavado gástrico e cultura de aspirado traqueal positivas. Devido a impossibilidade do uso da via oral decorrente da instabilidade hemodinâmica e do volumoso resíduo gástrico, foi administrado ivermectina subcutânea. Quatro dias após o tratamento com ivermectina e antibioticoterapia guiada por cultura, o paciente faleceu. A estrongiloidíase disseminada é desafio para a saúde mundial, principalmente na população transplantada, pois a infecção está correlacionada a uma alta mortalidade.
- 14 November 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (15)
Open AccessEstrongiloidíase disseminada em paciente de transplante renal e pancreático: revisão de literatura baseado em caso clínico
O Strongyloides stercoralis é um helminto com distribuição mundial. As manifestações clínicas da estrongiloidíase disseminada variam amplamente e os pacientes imunocomprometidos apresentam risco de infecção sintomática. Um paciente do sexo masculino de 38 anos foi submetido a transplante duplo de pâncreas-rim em dezembro de 2019 devido a diabetes mellitus tipo 1 e insuficiência renal crônica dialítica. O transplante ocorreu sem maiores intercorrências e o mesmo recebeu alta 10 dias após a realização do procedimento. Sessenta dias após o transplante foi internado na enfermaria de transplante renal apresentando náuseas, vômitos e dores abdominais iniciadas 5 dias antes. Com a possibilidade diagnóstica de gastroenterite infecciosa, foi iniciada antibioticoterapia. O paciente evoluiu com piora ventilatória associada a declínio do sensório, sendo encaminhado para Unidade de Terapia Intensiva, onde foi intubado e colocado em suporte ventilatório. Devido a piora clínica e hemodinâmica, necessitou iniciar de drogas vasoativas e aumentar o espectro da antibioticoterapia. Observou-se lesão serpiginosa púrpura em abdome, surgindo então a possibilidade de estrongiloidíase disseminada, posteriormente confirmada por lavado gástrico e cultura de aspirado traqueal positivas. Devido a impossibilidade do uso da via oral decorrente da instabilidade hemodinâmica e do volumoso resíduo gástrico, foi administrado ivermectina subcutânea. Quatro dias após o tratamento com ivermectina e antibioticoterapia guiada por cultura, o paciente faleceu. A estrongiloidíase disseminada é desafio para a saúde mundial, principalmente na população transplantada, pois a infecção está correlacionada a uma alta mortalidade.